Our results provide evidence that, in addition to Mn neurotoxicity, partial Mn deficiency that was corrected upon Mn treatment is a prominent feature of slc39a14 loss-of-function. The gene discussed is SLC39A14; the disease is hyperinsulinemic hypoglycemia, familial, 4.